Psychiatry & Neurology Doctors in Olney, MD Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Randy Levin, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 17833 Whimsey Ct, Olney, MD 20832 Phone: 301-570-4286

Dr. Nicholas Jacob Schor, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5004 Continental Dr, Olney, MD 20832 Phone: 301-774-7060    Fax: 301-774-7064

Dr. Khaled Abdelghany Khalafallah, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 18101 Prince Philip Dr, Olney, MD 20832 Phone: 301-774-8860

Dr. Morton Barry Albert, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3416 Olandwood Ct, Suite 201, Olney, MD 20832 Phone: 240-328-5580

John Feeney, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 2706 Thistledown Ter, Olney, MD 20832 Phone: 301-570-4768

Dr. Geoffrey Garland Grammer, M.D. Psychiatry & Neurology - Behavioral Neurology & Neuropsychiatry Medicare: Accepting Medicare Assignments Practice Location: 3460 Olney Laytonsville Rd Ste 212, Olney, MD 20832 Phone: 301-982-3437

Dr. Garsutis K. Palys, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3416 Olandwood Ct, Suite 201, Olney, MD 20832 Phone: 301-774-9400    Fax: 301-774-5542

News Archive

Psychological tools help high-risk chronic pain patients to taper opioid use

Psychological support and new coping skills are helping patients at high risk of developing chronic pain and long-term, high-dose opioid use taper their opioids and rebuild their lives with activities that are meaningful and joyful to them.

FDA grants orphan-drug designation to Genoa's pirfenidone for treatment of IPF disease

Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to Genoa for the use of pirfenidone in their lead program - inhaled GP-101 for the treatment of IPF.

Infant rotavirus vaccination reduced severe gastroenteritis among U.S. children

"Implementation of infant rotavirus vaccination in 2006 has substantially reduced the burden of severe gastroenteritis among U.S. children younger than 5 years," write Paul A. Gastanaduy, M.D., M.P.H., of the Centers for Disease Control and Prevention, Atlanta, and colleagues. "Whether indirect protection (due to reduced transmission of rotavirus) extends to adults remains unclear."

Microclimate and turbulent wind can influence COVID-19 spread over long distances

Respiratory particles exhaled after a sneeze can be transported by the turbulent wind more than three times further than current social or physical distancing measures recommend, reports a new study from Chile available on the preprint server medRxiv.

Read more Medical News

› Verified 3 days ago